Sheller Whistleblower Settlement: Florida Pain Practice Pays $750,000
2014-02-25 Sheller, P.C. announced today that Sarasota Pain Associates, P.A. (SPA) and its owner, Dr. Steven Chun, have agreed to pay $750,000 to resolve allegations by the law firm’s whistleblower clients that SPA violated the False Claims Act by submitting false claims to Medicare for procedures and services that he did not perform. During the time […]
Sheller Six Risperdal Settlements, Hundreds More Boys Represented
J&J to Pay at Least $2.5 Billion to Settle Hip Lawsuits
The Wall Street Journal 2013-11-19 The Wall Street Journal reports that Johnson & Johnson has agreed to pay at least $2.5 billion to settle nearly 8,000 hip implant lawsuits In its latest multibillion-dollar legal settlement, Johnson & Johnson has agreed to pay at least $2.5 billion to resolve thousands of lawsuits filed by patients who […]
$2.2 Billion Settlement
With the $2.2B Risperdal settlement, Sheller, P.C.’s representation of whistleblowers totals over $6.4 billion, with three of the top five pharmaceutical settlements in history 2009: Pfizer $2.3 billion (Geodon) 2009: Eli Lilly & Co. $1.4 billion (Zyprexa) 2013: Johnson & Johnson $2.2 billion (Risperdal, Invega) 2010 : Astra Zeneca $520 million (Seroquel) WASHINGTON, November 4, […]
Sheller settles Whistleblower UMass medical billing fraud case for 66k
The Boston Globe 2013-08-22 Worcester’s UMass Memorial Medical Center has settled fraud charges with the attorney general in a whistleblower case alleging that it improperly sent bills for uninsured patients to a homeless shelter, so it could tap the state for payments. On dozens of occasions, the hospital sent unpaid bills for emergency care to […]
Sheller Risperdal settlements front page Legal Intelligencer
2012-10-05 The first trial in which evidence was taken in the mass tort litigation over Risperdal, the antipsychotic drug that plaintiffs have claimed causes males to grow breasts, was settled as part of a group of five cases that resolved this week for undisclosed amounts, according to the plaintiffs’ lawyers and a statement from the […]
J&J agrees to settle five Risperdal suits
2012-10-04 Sheller attorneys announce that five Risperdal cases have been settled for confidential amounts. “Our clients are very pleased,” Steve Sheller, a plaintiffs’ attorney, said in a Bloomberg report after the settlement was announced. “I’ll never be truly satisfied because of what happened here with these kids. It’s a sad commentary on what goes on […]
J&J Settles with Sheller client on first day of Risperdal jury trial
Bloomberg BusinessWeek 2012-09-10 – Johnson & Johnson (JNJ) settled a lawsuit on the first day of a trial over claims its antipsychotic drug Risperdal caused a male plaintiff to grow breast tissue, one of his lawyers told a state judge in Philadelphia. Visit this page for up to date national and regional news coverage on Sheller, P.C.’s representation […]
Sheller Wins ‘Light’ Tobacco case, Potential Damages of Billions for Minnesota Consumers
2010-12-28 Attorneys Stephen Sheller and Martha Wivell represent plaintiffs in a class action lawsuit certified by the Minnesota Court of Appeals alleging that Philip Morris defrauded smokers of Marlboro Light cigarettes in that state. Filed in 2001, the class action could open the door to actual damages of total purchases in the billions of dollars […]
Jamie Sheller on special broadcast of The American Law Journal
2009-12-07 Jamie Sheller appeared on a special broadcast of The American Law Journal on Philadelphia’s CNN-News affiliate WFMZ. Sheller discussed her representation of the client and $2.5 million jury verdict in the first Paxil birth defects case. The program streamed live on the internet and was posted on blogs in the U.S. and U.K.
